Inventaire - your friends and communities are your best library

Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans

автор

Karen Cohen

Lisa K. Micklesfield

Gary Maartens

опубликовано в: PLOS ONE

дата публикации: 2015-12-03

язык: английский язык

главная тема: anti-retroviral agent, Эфавиренз

Cites articles 25

Дата

Заголовок

Авторы

2013-06

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach
2013-07-01

Incident fractures in HIV-infected individuals: a systematic review and meta-analysis

Stephanie Shiau
2013-09

Bone disease in the setting of HIV infection: update and review of the literature
2013-09-21

Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients

María Jesús Pérez-Elías
2013-05-30

Bone mass, body composition and vitamin D status of ARV-naïve, urban, black South African women with HIV infection, stratified by CD₄ count

Matthew M Hamill, Kate A Ward, John M. Pettifor
2013-06-01

Bone and vitamin D metabolism in HIV.
2012-11-09

Long-term HIV infection and antiretroviral therapy are associated with bone microstructure alterations in premenopausal women
2012-12-01

HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options

Mary T Bessesen
2012-02-16

Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal

Sabrina Eymard-Duvernay, Kirsten Bork, Eric Delaporte
2012-03

HIV: inflammation and bone
2012-04-01

Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.

Pablo Tebas
2012-03-06

Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy
2011-11-16

Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study
2011-10-24

Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa

Tolu Oni, Robert J. Wilkinson, Katalin A Wilkinson
2011-08-01

Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients

Gary Maartens, Estelle Lambert, Naomi S Levitt, Joel A Dave, Sacha West
2010-07-01

Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase

Fowzia Ibrahim
2010-01-01

Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.

Grace Mccomsey
2009-12-01

Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study

Alexandra Calmy, Bernard Hirschel
2009-08-01

Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.

Grace Mccomsey
2009-07

Metabolic bone disease in HIV infection

Maria Carla Re, Elisa De Crignis
2008-04-01

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study

Grace Mccomsey
2007-01-01

The association of bone mineral density with HIV infection and antiretroviral treatment in women

Nancy Hessol, Kathryn M. Anastos, Mardge H. Cohen, Phyllis C Tien
2006-11

Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review
2006-08-01

Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy

Mark Bolland, Anne Horne, Greg Gamble
1998-02-01

The lifetime total physical activity questionnaire: development and reliability

Christine M Friedenreich, Kerry S Courneya

Статья - wd:Q35859876

Добро пожаловать в Inventaire

the library of your friends and communities

узнать больше